CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $12.07 | $241K | 131,923 |
| 2026-03-10 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Option exercise | +1,546 | $33.51 | $52K | 15,912 |
| 2026-03-10 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Sale | −8,857 | $67.64 | $599K | 7,055 |
| 2026-03-10 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Option exercise · Option to Purchase Common Stock | −1,546 | $33.51 | $52K | 67,678 |
| 2026-03-09 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Option exercise | +20,000 | $33.51 | $670K | 34,366 |
| 2026-03-09 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Sale | −17,900 | $67.75 | $1.2M | 16,466 |
| 2026-03-09 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Sale | −2,100 | $68.25 | $143K | 14,366 |
| 2026-03-09 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Option exercise · Option to Purchase Common Stock | −20,000 | $33.51 | $670K | 69,224 |
| 2026-03-04 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +10,000 | $12.07 | $121K | 777,780 |
| 2026-03-04 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −7,329 | $69.94 | $513K | 770,451 |
| 2026-03-04 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −2,671 | $70.95 | $189K | 767,780 |
| 2026-03-04 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | $12.07 | $121K | 151,923 |
| 2026-03-03 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $12.07 | $241K | 787,780 |
| 2026-03-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −13,481 | $68.85 | $928K | 774,299 |
| 2026-03-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −6,519 | $69.33 | $452K | 767,780 |
| 2026-03-03 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $12.07 | $241K | 161,923 |
| 2026-03-02 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $12.07 | $241K | 787,780 |
| 2026-03-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −4,100 | $69.20 | $284K | 783,680 |
| 2026-03-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −15,322 | $69.80 | $1.1M | 768,358 |
| 2026-03-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −578 | $70.46 | $41K | 767,780 |
Page 8 of 26 · 513 trades